# Central Nervous System (CNS) Agents: Alzheimer’s Agents\*

## Length Of Authorizations

365 Days

## Grandfathering

Patients who have a claim for a non-preferred drug in the previous 120 days will be automatically approved to continue the drug. Patients who have taken the drug previously but do not have claims history (e.g. new to Medicaid), will need to submit a prior authorization in order to continue coverage.

## Prior Authorization Criteria

Is there any reason the patient cannot be changed to a medication not requiring prior approval? Acceptable reasons include:

-   Allergy to medications not requiring prior approval
-   Contraindication to or drug-to-drug interaction with medications not requiring prior approval
-   History of unacceptable/toxic side effects to medications not requiring prior approval

Has the patient failed a therapeutic trial of at least **30 days** with at least **two medications** not requiring prior approval?

## Alzheimer's Agents

Central Nervous System (CNS) Agents: Alzheimer’s Agents

| PREFERRED               | NON-PREFERRED      |
|-------------------------|--------------------|
| Donepezil 5mg, 10mg Tab | Donepezil 23mg Tab |
| Donepezil ODT           | Galantamine Sol    |
| Exelon Patch BvG        | Memantine ER       |
| Galantamine Tab         | Memantine Sol      |
| Galantamine ER Cap      | Namzaric           |
| Memantine Tab           | Rivastigmine Patch |
| Rivastigmine Cap        |                    |

### Link to Criteria

[Central Nervous System (CNS) Agents: Alzheimer’s Agents](https://pharmacy.medicaid.ohio.gov/sites/default/files/20220415_UPDL_Criteria_FINAL_.pdf#page=21)
